GNH USA

Europe — EMA

Meropenem Pontus Pharma D.O.O. (Meropenem Trihydrate)

GNH USA supplies Meropenem Pontus Pharma D.O.O. (Meropenem), a carbapenem antibiotic for complicated intra‑abdominal infections, urinary tract infections

Meropenem Trihydrate

Request sourcing

1
Pack/s

What is Meropenem Trihydrate?

Meropenem, the active ingredient in Meropenem Pontus Pharma D.O.O., is a carbapenem antibiotic presented as an injectable solution for intravenous use. It treats complicated intra‑abdominal infections, complicated urinary tract infections, nosocomial pneumonia and septicemia in hospitalized patients.

GNH USA supplies Meropenem Pontus Pharma D.O.O. as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

What is Meropenem Trihydrate used for?

Meropenem is a broad‑spectrum carbapenem antibiotic used for serious bacterial infections in the hospital setting.

- Complicated intra‑abdominal infections: achieves bacterial eradication and clinical cure in patients with perforated or postoperative abdominal infections. - Complicated urinary tract infections: eliminates resistant Gram‑negative pathogens causing severe UTIs. - Nosocomial pneumonia: provides effective coverage against hospital‑acquired respiratory pathogens. - Septicemia: rapidly reduces bacteremia and improves survival in systemic infections.

What are the side effects of Meropenem Trihydrate?

Meropenem may cause a range of adverse reactions, ranging from mild to severe.

Common Side Effects: - Diarrhea: mild to moderate gastrointestinal upset. - Nausea: occasional feeling of queasiness. - Headache: transient cranial discomfort. - Rash: mild skin erythema. - Elevated liver enzymes: transient increase in hepatic transaminases. - Injection site pain: discomfort at the IV site.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Seizures: especially in patients with renal impairment or CNS disorders. - Clostridioides difficile colitis: severe intestinal infection. - Thrombocytopenia: low platelet count leading to bleeding risk. - Renal dysfunction: acute kidney injury in susceptible individuals.

What precautions apply to Meropenem Trihydrate?

When using Meropenem, clinicians should consider several safety measures.

- Renal function: adjust dose in patients with impaired kidney function. - Hepatic function: monitor liver enzymes during prolonged therapy. - Pregnancy and lactation: use only if the potential benefit justifies the potential risk, as safety data are limited. - Concomitant nephrotoxic drugs: avoid or monitor closely to reduce kidney injury risk. - Allergies: assess for a history of β‑lactam hypersensitivity before initiation. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

What does Meropenem Trihydrate interact with?

Meropenem can interact with other medicines, influencing efficacy or safety.

Major Interactions (Avoid): - Valproic acid: may reduce serum valproate levels, risking seizure breakthrough. - Probenecid: can increase meropenem plasma concentrations, heightening toxicity risk.

Moderate Interactions (Monitor Closely): - Aminoglycosides: combined nephrotoxic potential; monitor renal function. - Loop diuretics: may enhance ototoxicity when used together. - Anticoagulants (e.g., warfarin): possible alteration of INR; check coagulation parameters.

Frequently asked questions

What infections is Meropenem Pontus Pharma D.O.O. used to treat?+
Meropenem Pontus Pharma D.O.O. is indicated for the treatment of serious hospital‑acquired infections such as complicated intra‑abdominal infections, complicated urinary tract infections, nosocomial pneumonia and septicemia. It is reserved for patients who need a broad‑spectrum carbapenem due to resistant or mixed bacterial pathogens.
How does Meropenem work to fight bacterial infections?+
Meropenem works by binding to penicillin‑binding proteins on bacterial cell walls, inhibiting the final step of peptidoglycan cross‑linking. This disruption weakens the cell wall, leading to osmotic instability and bacterial lysis. Its structure provides stability against most β‑lactamases, giving it activity against a wide range of Gram‑negative, Gram‑positive and anaerobic organisms.
What is the usual dose of Meropenem Pontus Pharma D.O.O.?+
The specific dose of Meropenem Pontus Pharma D.O.O. is determined by the prescribing clinician based on the infection type, severity, patient weight, renal function and local susceptibility patterns. Dosing regimens are individualized and should follow institutional guidelines or the product’s prescribing information.
Is Meropenem safe to use during pregnancy or breastfeeding?+
Safety data for Meropenem in pregnancy and lactation are limited. It should be used only if the potential benefit to the mother outweighs any possible risk to the fetus or infant. Clinicians should discuss the risk‑benefit profile with the patient and consider alternative therapies when appropriate.
How do I order Meropenem Pontus Pharma D.O.O. from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and any required import documentation.
How does Meropenem compare with other carbapenems like imipenem?+
Meropenem and imipenem belong to the same carbapenem class but differ in stability and spectrum. Meropenem is more stable against renal dehydropeptidase‑I, allowing use without a renal protective agent, and has a slightly broader activity against Pseudomonas aeruginosa. Both require dose adjustment in renal impairment and share similar safety profiles.
What are the recommended storage conditions for Meropenem Pontus Pharma D.O.O.?+
Meropenem Pontus Pharma D.O.O. should be stored refrigerated at 2‑8 °C. Keep the vials in their original packaging, protect from light, and avoid freezing or shaking. If the product reaches room temperature for a short period during administration, it may be used promptly but should be returned to refrigeration if not used.
How is Meropenem administered to patients?+
Meropenem is administered intravenously, typically as a bolus or short infusion over 15‑30 minutes. The infusion rate and dosing interval are selected by the prescriber based on infection severity, renal function and pharmacokinetic targets. Administration should follow aseptic technique and institutional infusion protocols.
What are the most serious risks associated with Meropenem therapy?+
Serious risks include hypersensitivity reactions such as anaphylaxis, seizure activity especially in patients with renal dysfunction or pre‑existing CNS disorders, and Clostridioides difficile‑associated colitis. Monitoring for neurological signs, allergic symptoms and gastrointestinal disturbances is essential during treatment.
Who should not receive Meropenem Pontus Pharma D.O.O.?+
Meropenem is contraindicated in patients with a known hypersensitivity to meropenem, other carbapenems, or any β‑lactam antibiotics. Caution is also advised for patients with a history of seizures, severe renal impairment without dose adjustment, or those receiving drugs that significantly lower the seizure threshold.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Meropenem Trihydrate
Route
Intravenous Use
Manufacturer
Pontus Pharma D.O.O.
Origin
EU

Related products

Archifar

Archifar

Meropenem Trihydrate

Medochemie Romania S.R.L.
EU
Luxomer

Luxomer

Meropenem Trihydrate

Sintesy Pharma S.R.L
EU
Luxomer

Luxomer

Meropenem Trihydrate

Sintesy Pharma S.R.L
EU
Merinfec

Merinfec

Meropenem Trihydrate

Actavis Group Ptc Ehf.
EU